Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40014557
Localisation
United Kingdom
Europe
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
10/04/2025
Statut
Classification
1.5°C
Année cible
FY2030
Statut
Targets set
Classification
1.5°C
Année cible
FY2045
Overall Net-Zero Target: Almac Group Limited commits to reach net-zero greenhouse gas emissions across the value chain by FY2045. Near-Term Targets: Almac Group Limited commits to reduce absolute scope 1 and 2 GHG emissions 50% by FY2030 from a FY2019 base year. Almac Group Limited also commits to reduce absolute scope 3 GHG emissions 27.5% within the same timeframe. Long-Term Targets: Almac Group Limited commits to reduce absolute scope 1 and 2 GHG emissions 95% by FY2045 from a FY2019 base year. Almac Group Limited also commits to reduce absolute scope 3 GHG emissions 90% within the same timeframe.
Statut
Targets setAnnée cible
FY2045
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
Source : Science Based Targets initiative | Données publiques